2019 European Thyroid Association Guidelines on the Management of Thyroid Dysfunction following Immune Reconstitution TherapyIlaria Muller, Colin Dayan, Carla Moran et al.|European Thyroid Journal|2019Cited by 76
Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studiesColin Dayan, Peter Senior, Sashiananthan Ganesananthan et al.|Multiple Sclerosis Journal - Experimental Translational and Clinical|2023Cited by 7
Outcomes in Alemtuzumab-Treated Patients With Thyroid Adverse Events: 6-Year Pooled CARE-MS Data (1509)Colin Dayan, Peter Senior, Beatriz Lecumberri et al.|Neurology|2021Cited by 0
Supplementary Material for: 2019 European Thyroid Association Guidelines on the Management of Thyroid Dysfunction following Immune Reconstitution TherapyIlaria Muller, Colin Dayan, Carla Moran et al.|Figshare|2019Cited by 0